Modern biobanks in Norway

Magnus, Per; Holmen, Jostein

doi:10.5324/nje.v25i1-2.1889

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Internationally, researchers are taking advantage of the benefits of integrating prospective designs and biospecimen collection. There are a growing number of large prospective longitudinal cohort studies that include biospecimens, for example in Norway 15 , the UK 2,16 and Taiwan. 17 These collections support the integration of 'omics' (e.g.…”

Section: Introductionmentioning

confidence: 99%

Unlocking the power of population health cohort studies with biobanking in Australia

Armanasco¹,

Lee²,

Liu³

et al. 2022

Public Health Res Pract.

View full text Add to dashboard Cite

Population-scale biobanks enhance opportunities to study disease and population health by enabling access to biomedical information that is linked with health, lifestyle and environmental data • Nesting biospecimen collection in cohort studies enables us to address research questions that were previously unanswerable • Although there are practical and ethical challenges related to population biobanking research, Australian cohort studies such as the 45 and Up Study can be enriched by biospecimen collection, because of their size, quality of data collected, and existing governance mechanisms

show abstract